Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_assertion type Assertion NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_head.
- NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_assertion description "[In the past, in melanoma, an increase in the number of positive tumour cells for Ki67 (detected by Mib1), cyclin A, cyclin D, MMP-2, integrins beta1 and beta3 or osteonectin were considered as factors of poor prognosis as well as the decrease in p16, p27, and Melan A.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_provenance.
- NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_assertion evidence source_evidence_literature NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_provenance.
- NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_assertion SIO_000772 16480699 NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_provenance.
- NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_assertion wasDerivedFrom befree-20140225 NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_provenance.
- NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_assertion wasGeneratedBy ECO_0000203 NP732605.RAO6PLm_6ky8Q4VlJZxpWMEYitwuLjAaCYerzx-mX57IM130_provenance.